Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 7, 2010, Pages 1164-1173

  George, Joseph ^a   Banik, Naren L ^b   Ray, Swapan K ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell invasion; Glioblastoma; HTERT; IFN ; Telomerase

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GAMMA INTERFERON; MYC PROTEIN; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; TELOMERASE; TERT PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MONOTHERAPY; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; CELL CYCLE; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; INTERFERON-GAMMA; NEOPLASM INVASIVENESS; RNA, MESSENGER; RNA, SMALL INTERFERING; TELOMERASE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 77953537979     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.04.002     Document Type: Article

References (35)

1. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795.
2. Burke F., East N., Upton C., Patel K., Balkwill F.R. Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Eur J Cancer 1997, 33:1114-1121.
3. Cabuy E., de Ridder L. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo. Virchows Arch 2001, 439:176-184.
4. Carpentier C., Lejeune J., Gros F., Everhard S., Marie Y., Kaloshi G., et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol 2007, 84:249-253.
5. Castro M.G., Cowen R., Williamson I.K., David A., Jimenez-Dalmaroni M.J., Yuan X., et al. Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther 2003, 98:71-108.
6. Cohen S.B., Graham M.E., Lovrecz G.O., Bache N., Robinson P.J., Reddel R.R. Protein composition of catalytically active human telomerase from immortal cells. Science 2007, 315:1850-1853.
7. Franken N.A., Rodermond H.M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319.
8. George J., Banik N.L., Ray S.K. Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochem Res 2009, 34:66-78.
9. George J., Banik N.L., Ray S.K. Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis, and tumour growth. J Cell Mol Med 2009, 13:4205-4218.
10. George J., Gondi C.S., Dinh D.H., Gujrati M., Rao J.S. Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis. Clin Cancer Res 2007, 13:3507-3517.
11. George J., Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther 2007, 14:790-803.
12. Hiraga S., Ohnishi T., Izumoto S., Miyahara E., Kanemura Y., Matsumura H., et al. Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 1998, 58:2117-2125.
13. Janardhanan R., Banik N.L., Ray S.K. N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cells. Cancer Lett 2008, 261:26-36.
14. Kano A., Haruyama T., Akaike T., Watanabe Y. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem Biophys Res Commun 1999, 257:672-677.
15. Kano A., Watanabe Y., Takeda N., Aizawa S., Akaike T. Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. J Biochem 1997, 121:677-683.
16. Kim K.S., Kang K.W., Seu Y.B., Baek S.H., Kim J.R. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech Ageing Dev 2009, 130:179-188.
17. Kirkpatrick K.L., Mokbel K. The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol 2001, 27:754-760.
18. Lee S.H., Kim J.W., Oh S.H., Kim Y.J., Rho S.B., Park K., et al. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer. FEBS Lett 2005, 579:1027-1033.
19. Maher S.G., Romero-Weaver A.L., Scarzello A.J., Gamero A.M. Interferon: cellular executioner or white knight?. Curr Med Chem 2007, 14:1279-1289.
20. Masutomi K., Hahn W.C. Telomerase and tumorigenesis. Cancer Lett 2003, 194:163-172.
21. McElwain D.L., Pettet G.J. Cell migration in multicell spheroids: swimming against the tide. Bull Math Biol 1993, 55:655-674.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
23. Qian X., Cheng J., Chen A., Wang Y., Tao Y., Cao J., et al. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity. Oncol Rep 2008, 19:575-581.
24. Sangfelt O., Erickson S., Castro J., Heiden T., Gustafsson A., Einhorn S., et al. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene 1999, 18:2798-2810.
25. Sato N., Maehara N., Mizumoto K., Nagai E., Yasoshima T., Hirata K., et al. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer 2001, 91:496-504.
26. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
27. Sen G.C. Viruses and interferons. Annu Rev Microbiol 2001, 55:255-281.
28. Shay J.W., Zou Y., Hiyama E., Wright W.E. Telomerase and cancer. Hum Mol Genet 2001, 10:677-685.
29. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264.
30. Tchirkov A., Rolhion C., Kémény J.L., Irthum B., Puget S., Khalil T., et al. Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas. Br J Cancer 2003, 88:516-520.
31. Tolboom T.C., Huizinga T.W. In vitro matrigel fibroblast invasion assay. Methods Mol Med 2007, 135:413-422.
32. Wang L., Wei Q., Wang L.E., Aldape K.D., Cao Y., Okcu M.F., et al. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 2006, 24:1627-1632.
33. Wang Y., Liu D., Chen P., Koeffler H.P., Tong X., Xie D. Negative feedback regulation of IFN-γ pathway by IFN regulatory factor 2 in esophageal cancers. Cancer Res 2008, 68:1136-1143.
34. Xi L., Chen G., Zhou J., Xu G., Wang S., Wu P., et al. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis 2006, 11:789-798.
35. Zhao P., Wang C., Fu Z., You Y., Cheng Y., Lu X., et al. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner. Int J Oncol 2007, 31:361-368.